The immunoproteasome, the 20S proteasome and the PA28αβ proteasome regulator are oxidative-stress-adaptive proteolytic complexes

Author(s): Pickering AM, Koop AL, Teoh CY, Ermak G, Grune T, et al.

Abstract

Oxidized cytoplasmic and nuclear proteins are normally degraded by the proteasome, but accumulate with age and disease. We demonstrate the importance of various forms of the proteasome during transient (reversible) adaptation (hormesis), to oxidative stress in murine embryonic fibroblasts. Adaptation was achieved by 'pre-treatment' with very low concentrations of H2O2, and tested by measuring inducible resistance to a subsequent much higher 'challenge' dose of H2O2. Following an initial direct physical activation of pre-existing proteasomes, the 20S proteasome, immunoproteasome and PA28αβ regulator all exhibited substantially increased de novo synthesis during adaptation over 24 h. Cellular capacity to degrade oxidatively damaged proteins increased with 20S proteasome, immunoproteasome and PA28αβ synthesis, and was mostly blocked by the 20S proteasome, immunoproteasome and PA28 siRNA (short interfering RNA) knockdown treatments. Additionally, PA28αβ-knockout mutants achieved only half of the H2O2-induced adaptive increase in proteolytic capacity of wild-type controls. Direct comparison of purified 20S proteasome and immunoproteasome demonstrated that the immunoproteasome can selectively degrade oxidized proteins. Cell proliferation and DNA replication both decreased, and oxidized proteins accumulated, during high H2O2 challenge, but prior H2O2 adaptation was protective. Importantly, siRNA knockdown of the 20S proteasome, immunoproteasome or PA28αβ regulator blocked 50-100% of these adaptive increases in cell division and DNA replication, and immunoproteasome knockdown largely abolished protection against protein oxidation.

Similar Articles

Inhibition of carcinogenesis by tea

Author(s): Yang CS, Maliakal P, Meng X

Prostate cancer chemoprevention by green tea

Author(s): Gupta S, Ahmad N, Mukhtar H

Apoptosis-inducing activity of high molecular weight fractions of tea extracts

Author(s): Hayakawa S, Kimura T, Saeki K, Koyama Y, Aoyagi Y, et al.

Apoptosis induction by epigallocatechin gallate involves its binding to Fas

Author(s): Hayakawa S, Saeki K, Sazuka M, Suzuki Y, Shoji Y, et al.

Synthetic analogs of green tea polyphenols as proteasome inhibitors

Author(s): Smith DM, Wang Z, Kazi A, Li LH, Chan TH, et al.

The proteasome: paradigm of a self-compartmentalizing protease

Author(s): Baumeister W, Walz J, Zühl F, Seemüller E

Activation domain-dependent monoubiquitylation of Gal4 protein is essential for promoter binding in vivo

Author(s): Archer CT, Delahodde A, Gonzalez F, Johnston SA, Kodadek T

Physical and functional association of RNA polymerase II and the proteasome

Author(s): Gillette TG, Gonzalez F, Delahodde A, Johnston SA, Kodadek T

Recruitment of a 19S proteasome subcomplex to an activated promoter

Author(s): Gonzalez F, Delahodde A, Kodadek T, Johnston SA

The 19S complex of the proteasome regulates nucleotide excision repair in yeast

Author(s): Gillette TG, Huang W, Russell SJ, Reed SH, Johnston SA, et al.

Distinct functions of the ubiquitin-proteasome pathway influence nucleotide excision repair

Author(s): Gillette TG, Yu S, Zhou Z, Waters R, Johnston SA, et al.

Synergistic effect of green tea catechins on cell growth and apoptosis induction in gastric carcinoma cells

Author(s): Horie N, Hirabayashi N, Takahashi Y, Miyauchi Y, Taguchi H, et al.

Lactacystin, proteasome function, and cell fate

Author(s): Fenteany G, Schreiber SL

Apoptosis induced by proteasome inhibition in cancer cells: predominant role of the p53/PUMA pathway

Author(s): Concannon CG, Koehler BF, Reimertz C, Murphy BM, Bonner C, et al.

Caspases and apoptosis

Author(s): Salvesen GS

NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1

Author(s): Guttridge DC, Albanese C, Reuther JY, Pestell RG, Baldwin AS Jr

Tea polyphenols, their biological effects and potential molecular targets

Author(s): Chen D, Milacic V, Chen MS, Wan SB, Lam WH, et al.